Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Gonadotropin-releasing hormone antagonist dosing regimens for treating uterine fibroids and reducing menstrual blood loss

Gonadotropin-releasing hormone antagonist dosing regimens for treating uterine fibroids and reducing menstrual blood loss

US Patent 11759464 · Granted Sep 19, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for the treatment of adenomyosis and rectovaginal endom2025
Compositions and methods for the treatment of adenomyosis and rectovaginal endom2025
Gonadotropin-releasing hormone antagonist dosing regimens for the treatment of e2024
Gonadotropin-releasing hormone antagonist dosing regimens for the treatment of e2024
Compositions and methods for delaying the incidence of labor2022
Compositions and methods for delaying the incidence of labor2022
Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt 2022
Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt 2022
Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt 2022
Oral formulations of pyrrolidine derivatives2022
Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt 2020
Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt 2020